GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (FRA:9U90) » Definitions » Non Operating Income

Unity Biotechnology (FRA:9U90) Non Operating Income : €4.63 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Unity Biotechnology's Non Operating Income for the three months ended in Sep. 2024 was €-0.25 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 was €4.63 Mil.

Unity Biotechnology Non Operating Income Historical Data

The historical data trend for Unity Biotechnology's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Non Operating Income Chart

Unity Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Non Operating Income
Get a 7-Day Free Trial 4.98 -1.98 -0.87 14.58 -1.12

Unity Biotechnology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.55 2.58 1.19 1.10 -0.25

Unity Biotechnology Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unity Biotechnology Non Operating Income Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (FRA:9U90) » Definitions » Non Operating Income
Comparable Companies
NERV ALGS LTRN NRXP MAIA SEEL LUMO NLTX PTN SIOX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
UBX:USA 0YC0:UK 9U90:Germany
Address
285 East Grand Avenue, South San Francisco, CA, USA, 94080
Website
https://www.unitybiotechnology.com
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Unity Biotechnology Headlines

No Headlines